Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - CALMARE THERAPEUTICS Inc | s101719_31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - CALMARE THERAPEUTICS Inc | s101719_32-1.htm |
| 10-Q - 10-Q - CALMARE THERAPEUTICS Inc | s101719_10-q.htm |
| EX-31.1 - EXHIBIT 31.1 - CALMARE THERAPEUTICS Inc | s101719_31-1.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.SC. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Calmare Therapeutics Incorporated (the “Company”) on Form 10-Q for the period ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Ian Rhodes, chief financial officer of the Company, certifies, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: October 13, 2015 | By: | /s/ Ian Rhodes |
|
Ian Rhodes Executive Vice President and Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer) |
This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.